Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $1.74 and traded as low as $1.38. Evotec shares last traded at $1.38, with a volume of 82,404 shares traded.
Evotec Stock Up 4.2%
The firm has a 50 day moving average of $1.72 and a two-hundred day moving average of $2.34. The firm has a market capitalization of $488.73 million, a price-to-earnings ratio of 3.61 and a beta of 0.98. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53.
About Evotec
Evotec SE is a Germany-based biotechnology company that provides drug discovery and development services to pharmaceutical, biotechnology and academic partners. The company combines scientific expertise, technology platforms and proprietary research programs to support the identification and advancement of potential medicines.
Its activities span early-stage research and development, including target identification and validation, assay development, screening, medicinal chemistry, computational drug design, pharmacology and preclinical development.
Further Reading
- Five stocks we like better than Evotec
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
